Exterior of the Porsolt building with a large sign displaying the company logo and the slogan "Scientist to Scientist." The building features modern architecture with blue and white panels, large windows, and landscaped greenery, under a partly cloudy sky.

Porsolt

GLP-compliant preclinical CRO services for CNS, safety pharmacology, and behavioral pharmacology.

Porsolt delivers preclinical research services covering central nervous system studies, safety pharmacology, and behavioral pharmacology — supporting pharma and biotech R&D from screening through pre-Phase 1. Founded in France in 1985 with 70,000+ sq ft of A-grade GLP laboratory space and majority-owned by Apax Partners.

Engage NSS for Porsolt → contact@northstarsci.com

Service portfolio

  • CNS preclinical studies — psychopharmacology, epilepsy, neurodegenerative disorders, sleep-wake research

  • Safety pharmacology — full ICH S7 packages including arrhythmogenic risk and abuse/dependence liability

  • Behavioral pharmacology — drug discovery models across multiple therapeutic areas

  • In vitro, in ovo, ex vivo, and in vivo models across multiple species

  • On-site drug formulation and bioanalysis

  • Full preclinical support from screening through pre-Phase 1 regulatory studies

Who Porsolt is for

  • Pharma preclinical R&D teams running discovery and development studies

  • Biotech companies advancing CNS, neurology, or behavioral candidates

  • Drug discovery teams needing GLP-compliant safety packages

  • Regulatory affairs teams preparing pre-IND submissions

Why North Star Scientific represents Porsolt

NSS is the commercial partner for Porsolt in the United States and Canada. Our team brings 25+ years of life science commercial experience to introducing Porsolt's preclinical services to pharma and biotech R&D teams who need GLP-compliant studies and a trusted preclinical research partner.

What NSS handles for Porsolt:

  • Outbound prospecting to pharma preclinical R&D and discovery teams

  • AI-personalized multi-channel outreach across email, LinkedIn, voice, and phone

  • In-person trade show representation at SOT, ACT, and pharma R&D conferences

  • Account-level engagement with major pharma and biotech sponsors

  • Pipeline management and monthly reporting to the Porsolt commercial team

How to engage

Coverage: United States and Canada NSS team: Pat Téa, Jeff Storelee Contact: contact@northstarsci.com | 1-888-565-4957

For full service capabilities, study design consultation, and proposal requests:

Get in touch about Porsolt